Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL863125 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL863128 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| Diethylene Glycol Diisobutanoate SCHEMBL9561713 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL863288 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL7637824 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| Ethylene Glycol Diisobutanoate SCHEMBL843146 | 0.91 | TSHR (0.36) | ALDH1A1TSHRCHRNB2CHRNA4 | |
| SCHEMBL17976921 | 0.91 | MEN1 (0.50) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL6032764 | 0.91 | MEN1 (0.50) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL12390088 | 0.91 | HSD17B10 (0.43) | ALDH1A1TSHRTP53HIF1AHSD17B10 | |
| SCHEMBL16021805 | 0.91 | ALDH1A1 (0.58) | ALDH1A1TSHRTP53HIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4092003-B1 | RESIN COMPOSITION, RESIN SHEET, AND LAMINATED GLASS | KURARAY CO (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-20230069427-A1 | RESIN COMPOSITION, RESIN SHEET, AND LAMINATED GLASS | KURARAY CO., LTD. (JP) | 2023-03-02 | — | — | US | disclosed |
| EP-4092003-A1 | RESIN COMPOSITION, RESIN SHEET, AND LAMINATED GLASS | Kuraray Co., Ltd. (JP) | 2022-11-23 | — | — | EP | disclosed |
| US-11325354-B2 | Interlayer film for laminated glass | KURARAY CO., LTD. (JP) | 2022-05-10 | — | — | US | disclosed |
| WO-2021145137-A1 | RESIN COMPOSITION, RESIN SHEET, AND LAMINATED GLASS | 株式会社クラレ | 2021-07-22 | — | — | WO | disclosed |
| US-20200298535-A1 | INTERLAYER FILM FOR LAMINATED GLASS | KURARAY CO., LTD. (JP) | 2020-09-24 | — | — | US | disclosed |
| EP-2463336-B1 | POLYVINYL ACETAL COMPOSITION, LAMINATE, AND USE THEREOF | KURARAY CO (JP) | 2019-10-02 | — | — | EP | disclosed |
| EP-3029090-B1 | POLYVINYL ACETAL FILM EXCELLENT IN TRANSPARENCY AND SUPRESSING THERMAL CRACKING PHENOMENON | KURARAY CO (JP) | 2019-05-29 | — | — | EP | disclosed |
| EP-3438065-A1 | INTERMEDIATE FILM FOR LAMINATED GLASS | Kuraray Co., Ltd. (JP) | 2019-02-06 | — | — | EP | disclosed |
| EP-2347898-B1 | MULTILAYER BODY | KURARAY CO (JP) | 2017-06-07 | — | — | EP | disclosed |
| US-8754237-B2 | Bifunctional histone deacetylase inhibitors | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-06-17 | — | — | US | disclosed |
| US-8722194-B2 | Polyvinyl acetal composition, laminate, and use thereof | KURARAY CO., LTD. (JP) | 2014-05-13 | — | — | US | disclosed |
| US-20130018103-A1 | BIFUNCTIONAL HISTONE DEACETYLASE INHIBITORS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2013-01-17 | — | — | US | disclosed |
| US-20120204940-A1 | POLYVINYL ACETAL LAMINATE AND USE THEREOF | KURARAY CO., LTD. (JP) | 2012-08-16 | — | — | US | disclosed |
| US-20120202070-A1 | POLYVINYL ACETAL COMPOSITION, LAMINATE, AND USE THEREOF | KURARAY CO., LTD. (JP) | 2012-08-09 | — | — | US | disclosed |
| US-8222423-B2 | Bifunctional histone deacetylase inhibitors | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2012-07-17 | — | — | US | disclosed |
| EP-2463336-A1 | POLYVINYL ACETAL COMPOSITION, LAMINATE, AND USE THEREOF | Kuraray Co., Ltd. (JP) | 2012-06-13 | — | — | EP | disclosed |
| EP-2463095-A1 | POLYVINYL ACETAL LAMINATE AND USE THEREOF | Kuraray Co., Ltd. (JP) | 2012-06-13 | — | — | EP | disclosed |
| EP-2347898-A1 | MULTILAYER BODY | Kuraray Co., Ltd. (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-20090312363-A1 | BIFUNCTIONAL HISTONE DEACETYLASE INHIBITORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2009-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018103-A1 | BIFUNCTIONAL HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC11, HDAC2 | ALDH1A1 786/4885TSHR 3624/4885TP53 377/4885 |
| US-20090312363-A1 | BIFUNCTIONAL HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC11, HDAC2 | ALDH1A1 786/4885TSHR 3624/4885TP53 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.